COVID-19, steroids, and mucormycosis: What an ophthalmologist should know
Indian J Ophthalmol
.
2021 Jul;69(7):1970.
doi: 10.4103/ijo.IJO_1143_21.
Authors
Abhishek Tandon
1
,
Latika Pandey
2
Affiliations
1
Department of Pulmonary, Critical Care and Sleep Study, AIIMS, Jodhpur, Rajasthan, India.
2
Regional Institute of Ophthalmology, Pt. B.D. Sharma, PGIMS, Rohtak, Haryana, India.
PMID:
34146077
PMCID:
PMC8374827
DOI:
10.4103/ijo.IJO_1143_21
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
Mucormycosis* / diagnosis
Mucormycosis* / drug therapy
Ophthalmologists*
SARS-CoV-2
Steroids
Substances
Steroids